Saad Bin Toufeeq
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Saad Bin Toufeeq has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Nabeel Ahmad
Lahore General Hospital
4 shared publications - Neykzad Wadeer
Department of General Surgery, CURE International Hospital, Kabul, Afghanistan
3 shared publications Ahmad Sama
Lahore General Hospital Ameer‐Ud‐Din Medical College Lahore Pakistan
1 shared publication- Ali Bin Toufeeq
Lahore General Hospital International School of Medicine/International University of Kyrgyzstan Bishkek Kyrgyzstan
1 shared publication Ali Toufeeq
Lahore General Hospital
1 shared publicationAmmara Arshad
Lahore General Hospital
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (7) , 2469-2473
Acuphagia with sequential ingestion of sharp metallic objects and a magnet, causing intestinal bezoar, perforation, and peritonitis: a case report
Introduction and importance: Acuphagia is a rare psychopathological subtype of pica, characterized by the deliberate ingestion of sharp metallic objects. It can lead to life-threatening complications, including intestinal obstruction, perforation, and peritonitis, and, in severe cases, death. The subsequent ingestion of a magnet further increases the risk of complications. Case presentation: We report a unique case of a 16-year-old boy with no prior psychiatric diagnosis, presenting with severe abdominal pain for 2 months, absolute constipation for the last 4 days, along with fever and vomiting. History revealed sequential ingestion of small metallic bolts followed by a magnet. Clinical examination and imaging showed clustered radiopaque foreign bodies in the small bowel, causing intestinal obstruction and secondary peritonitis. Emergency exploratory laparotomy revealed five discrete perforations (three jejunal and two ileal). A 23 cm segment of the jejunum was resected to remove 15 metallic bolts and a magnet, followed by primary anastomosis, while two ileal perforations were managed with primary closure. Postoperatively, the patient was diagnosed with major depressive disorder and started on selective serotonin reuptake inhibitors and cognitive behavioral therapy. Discussion: The magnet likely caused clustering of previously ingested metallic bolts, forming a “metallic bezoar” that led to obstruction and perforation. This necessitated jejunal resection due to multiple perforations and pressure necrosis. This manuscript highlights the need to reconsider symptom-based postoperative imaging strategies. The patient’s vocational environment was a key diagnostic clue. Conclusion: Early recognition and prompt surgical intervention are essential in high-risk cases. A multidisciplinary approach, including psychiatric management and follow-up, is crucial to prevent recurrence.
- 1 June 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (7) , 2469-2473
Open AccessAcuphagia with sequential ingestion of sharp metallic objects and a magnet, causing intestinal bezoar, perforation, and peritonitis: a case report
Introduction and importance: Acuphagia is a rare psychopathological subtype of pica, characterized by the deliberate ingestion of sharp metallic objects. It can lead to life-threatening complications, including intestinal obstruction, perforation, and peritonitis, and, in severe cases, death. The subsequent ingestion of a magnet further increases the risk of complications. Case presentation: We report a unique case of a 16-year-old boy with no prior psychiatric diagnosis, presenting with severe abdominal pain for 2 months, absolute constipation for the last 4 days, along with fever and vomiting. History revealed sequential ingestion of small metallic bolts followed by a magnet. Clinical examination and imaging showed clustered radiopaque foreign bodies in the small bowel, causing intestinal obstruction and secondary peritonitis. Emergency exploratory laparotomy revealed five discrete perforations (three jejunal and two ileal). A 23 cm segment of the jejunum was resected to remove 15 metallic bolts and a magnet, followed by primary anastomosis, while two ileal perforations were managed with primary closure. Postoperatively, the patient was diagnosed with major depressive disorder and started on selective serotonin reuptake inhibitors and cognitive behavioral therapy. Discussion: The magnet likely caused clustering of previously ingested metallic bolts, forming a “metallic bezoar” that led to obstruction and perforation. This necessitated jejunal resection due to multiple perforations and pressure necrosis. This manuscript highlights the need to reconsider symptom-based postoperative imaging strategies. The patient’s vocational environment was a key diagnostic clue. Conclusion: Early recognition and prompt surgical intervention are essential in high-risk cases. A multidisciplinary approach, including psychiatric management and follow-up, is crucial to prevent recurrence.
- Open Access
- 22 May 2026
- Published by Pakistan Society of Gastroenterology and GI Endoscopy in Pakistan journal of Gastroenterology
- Vol. 42 (1) , 883-889
Aprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Background: Cyclical vomiting syndrome (CVS) is a disorder of gut–brain interaction characterized by recurrent, stereotyped episodes of intense nausea and vomiting with return to baseline in between. Pediatric CVS often leads to frequent hospitalizations, comorbidities, and poor quality of life. Standard abortive therapies include 5-HT₃ antagonists (e.g. ondansetron) and triptans, while prophylaxis may involve cyproheptadine or amitriptyline. Aprepitant, an oral neurokinin-1 (NK1) receptor antagonist approved for chemotherapy-induced nausea, is increasingly used off-label in refractory pediatric CVS. Its efficacy and safety in this setting remain unclear. Methods: We conducted a PRISMA-style systematic review of studies reporting on aprepitant in pediatric CVS. We searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library from inception to 15 January 2025 for any study (randomized trials, cohorts, case series, reports) of aprepitant in children (<18) with CVS. Two reviewers independently screened records, extracted data, and assessed risk of bias using standard tools. Outcomes were patient-reported response (episode frequency/intensity), healthcare utilization (episodes/year, admissions), and adverse events. Due to heterogeneity, results are summarized narratively. Results: No randomized controlled trials were identified. Evidence consisted of one retrospective controlled cohort study, one retrospective single-center case series, and one case report, with mixed findings and overall low certainty. We included three studies (total n≈1817): one large retrospective controlled cohort (Thavamani et al. 2024; n=1775, 96 received aprepitant), one single-center retrospective series (Cristofori et al. 2014; n=41), and one single-patient case report (Nivatsi et al. 2021). In the Thavamani cohort, aprepitant use as an abortive agent did not reduce 7-day readmission rates (17% vs. 16%, p=0.91), although those receiving aprepitant had more severe initial illness (longer stay: 5 vs. 3 days; higher costs: \$11,790 vs. \$6,380). Cristofori et al. reported that 81% of children on prophylactic aprepitant and 76% on abortive aprepitant had complete or partial clinical response at 12 months. Both subgroups showed significant reductions in CVS episodes per year, hospital admissions, episode duration, and improved school attendance. Side effects occurred only in the prophylactic group (31% of children) and were mild (hiccups, fatigue, appetite increase, headache, migraine). The single case (13-year-old girl) had failed standard therapy but experienced complete cessation of vomiting after starting brief oral aprepitant at prodrome. Limitations: All evidence is from observational or anecdotal reports with high risk of bias. The cohort used administrative data without randomized assignment, and the retrospective series lacked a control group. Adverse events were sparsely reported. Conclusion: Preliminary evidence suggests aprepitant can reduce symptoms in refractory pediatric CVS and is well tolerated, but a large multicenter RCT is needed. Current data are insufficient to endorse routine use; aprepitant may be considered in severe, treatment-refractory cases under specialist care.
- 22 May 2026
- Published by Pakistan Society of Gastroenterology and GI Endoscopy in Pakistan journal of Gastroenterology
- Vol. 42 (1) , 883-889
Open AccessAprepitant Use in Pediatric Cyclical Vomiting Syndrome: A Systematic Review
Background: Cyclical vomiting syndrome (CVS) is a disorder of gut–brain interaction characterized by recurrent, stereotyped episodes of intense nausea and vomiting with return to baseline in between. Pediatric CVS often leads to frequent hospitalizations, comorbidities, and poor quality of life. Standard abortive therapies include 5-HT₃ antagonists (e.g. ondansetron) and triptans, while prophylaxis may involve cyproheptadine or amitriptyline. Aprepitant, an oral neurokinin-1 (NK1) receptor antagonist approved for chemotherapy-induced nausea, is increasingly used off-label in refractory pediatric CVS. Its efficacy and safety in this setting remain unclear. Methods: We conducted a PRISMA-style systematic review of studies reporting on aprepitant in pediatric CVS. We searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Library from inception to 15 January 2025 for any study (randomized trials, cohorts, case series, reports) of aprepitant in children (<18) with CVS. Two reviewers independently screened records, extracted data, and assessed risk of bias using standard tools. Outcomes were patient-reported response (episode frequency/intensity), healthcare utilization (episodes/year, admissions), and adverse events. Due to heterogeneity, results are summarized narratively. Results: No randomized controlled trials were identified. Evidence consisted of one retrospective controlled cohort study, one retrospective single-center case series, and one case report, with mixed findings and overall low certainty. We included three studies (total n≈1817): one large retrospective controlled cohort (Thavamani et al. 2024; n=1775, 96 received aprepitant), one single-center retrospective series (Cristofori et al. 2014; n=41), and one single-patient case report (Nivatsi et al. 2021). In the Thavamani cohort, aprepitant use as an abortive agent did not reduce 7-day readmission rates (17% vs. 16%, p=0.91), although those receiving aprepitant had more severe initial illness (longer stay: 5 vs. 3 days; higher costs: \$11,790 vs. \$6,380). Cristofori et al. reported that 81% of children on prophylactic aprepitant and 76% on abortive aprepitant had complete or partial clinical response at 12 months. Both subgroups showed significant reductions in CVS episodes per year, hospital admissions, episode duration, and improved school attendance. Side effects occurred only in the prophylactic group (31% of children) and were mild (hiccups, fatigue, appetite increase, headache, migraine). The single case (13-year-old girl) had failed standard therapy but experienced complete cessation of vomiting after starting brief oral aprepitant at prodrome. Limitations: All evidence is from observational or anecdotal reports with high risk of bias. The cohort used administrative data without randomized assignment, and the retrospective series lacked a control group. Adverse events were sparsely reported. Conclusion: Preliminary evidence suggests aprepitant can reduce symptoms in refractory pediatric CVS and is well tolerated, but a large multicenter RCT is needed. Current data are insufficient to endorse routine use; aprepitant may be considered in severe, treatment-refractory cases under specialist care.
- Open Access
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Secondary Dengue Infection Presenting With Kawasaki Disease–Like Features: A Diagnostic Dilemma in a 12‐Year‐Old Girl
In dengue‐endemic regions, prolonged fever with mucocutaneous findings may represent classical Kawasaki disease (KD), dengue‐associated KD‐like inflammation, or true concomitant disease. When KD cannot be confidently excluded, timely IVIG administration may be justified to prevent coronary complications. Structured follow‐up including serial echocardiography remains essential.
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Open AccessSecondary Dengue Infection Presenting With Kawasaki Disease–Like Features: A Diagnostic Dilemma in a 12‐Year‐Old Girl
In dengue‐endemic regions, prolonged fever with mucocutaneous findings may represent classical Kawasaki disease (KD), dengue‐associated KD‐like inflammation, or true concomitant disease. When KD cannot be confidently excluded, timely IVIG administration may be justified to prevent coronary complications. Structured follow‐up including serial echocardiography remains essential.
- Open Access
- 28 March 2026
- Published by Health Services Academy in Pakistan Journal of Public Health
- Vol. 16 (1)
One Patient, One Attendant: An Overlooked Necessity for Better Patient Care in Pakistan’s Tertiary Care Hospitals
Massive footfall of patients in tertiary care hospitals across Pakistan has become a chronic challenge. These hospitals are overwhelmed not only by patients but also by large groups of attendants accompanying each patient, turning wards into congested, chaotic spaces compromising patient care. An article of DAWN mentions about Non-cooperative behaviour of attendants, who insisted on staying with their patients, also contributed to the overcrowding (1). Although, “one patient, one attendant” policies are being displayed in most of the wards, but enforcement of this very policy remains almost nonexistent. Most patients are accompanied by several attendants who crowd the bedside, restrict staff movement, and interfere during rounds and procedures. One of the major precipitating factor in Pakistani doctors’ burnout and over exhaustion in an already over worked environment is the unwarranted and unnecessary presence of a patient’s attendants in, sometimes, a critical life threatening scenario where either you manage the attendants or save a life. Such encounters lead to arguments, delays, and sometimes violence (2), further highlighting the urgent need for strict policy enforcement. The influx of unnecessary attendants disrupts doctors’ and nurses’ workflow, increases infection risk and compromises patient privacy and adds to hospital waste and resource strain.
- 28 March 2026
- Published by Health Services Academy in Pakistan Journal of Public Health
- Vol. 16 (1)
Open AccessOne Patient, One Attendant: An Overlooked Necessity for Better Patient Care in Pakistan’s Tertiary Care Hospitals
Massive footfall of patients in tertiary care hospitals across Pakistan has become a chronic challenge. These hospitals are overwhelmed not only by patients but also by large groups of attendants accompanying each patient, turning wards into congested, chaotic spaces compromising patient care. An article of DAWN mentions about Non-cooperative behaviour of attendants, who insisted on staying with their patients, also contributed to the overcrowding (1). Although, “one patient, one attendant” policies are being displayed in most of the wards, but enforcement of this very policy remains almost nonexistent. Most patients are accompanied by several attendants who crowd the bedside, restrict staff movement, and interfere during rounds and procedures. One of the major precipitating factor in Pakistani doctors’ burnout and over exhaustion in an already over worked environment is the unwarranted and unnecessary presence of a patient’s attendants in, sometimes, a critical life threatening scenario where either you manage the attendants or save a life. Such encounters lead to arguments, delays, and sometimes violence (2), further highlighting the urgent need for strict policy enforcement. The influx of unnecessary attendants disrupts doctors’ and nurses’ workflow, increases infection risk and compromises patient privacy and adds to hospital waste and resource strain.
- Open Access
- 22 December 2025
- Published by Wiley
DENGUE FEVER MIMICKING CLINICAL FEATURES OF KD IMPROVED WITH IVIG IN A 12 YEAR OLD GIRL: A DIAGNOSTIC PITFALL
- 22 December 2025
- Published by Wiley
Open AccessDENGUE FEVER MIMICKING CLINICAL FEATURES OF KD IMPROVED WITH IVIG IN A 12 YEAR OLD GIRL: A DIAGNOSTIC PITFALL